Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept.
artificial intelligence
chemoradiation (CRT)
locally advanced cervical cancer
multidisciplinary tumor board smart virtual assistant
virtual medicine support
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
11
2021
accepted:
08
12
2021
entrez:
20
1
2022
pubmed:
21
1
2022
medline:
21
1
2022
Statut:
epublish
Résumé
The first prototype of the "Multidisciplinary Tumor Board Smart Virtual Assistant" is presented, aimed to (i) Automated classification of clinical stage starting from different free-text diagnostic reports; (ii) Resolution of inconsistencies by identifying controversial cases drawing the clinician's attention to particular cases worthy for multi-disciplinary discussion; (iii) Support environment for education and knowledge transfer to junior staff; (iv) Integrated data-driven decision making and standardized language and interpretation. Data from patients affected by Locally Advanced Cervical Cancer (LACC), FIGO stage IB2-IVa, treated between 2015 and 2018 were extracted. Magnetic Resonance (MR), Gynecologic examination under general anesthesia (EAU), and Positron Emission Tomography-Computed Tomography (PET-CT) performed at the time of diagnosis were the items from the Electronic Health Records (eHRs) considered for analysis. An automated extraction of eHR that capture the patient's data before the diagnosis and then, through Natural Language Processing (NLP), analysis and categorization of all data to transform source information into structured data has been performed. In the first round, the system has been used to retrieve all the eHR for the 96 patients with LACC. The system has been able to classify all patients belonging to the training set and - through the NLP procedures - the clinical features were analyzed and classified for each patient. A second important result was the setup of a predictive model to evaluate the patient's staging (accuracy of 94%). Lastly, we created a user-oriented operational tool targeting the MTB who are confronted with the challenge of large volumes of patients to be diagnosed in the most accurate way. This is the first proof of concept concerning the possibility of creating a smart virtual assistant for the MTB. A significant benefit could come from the integration of these automated methods in the collaborative, crucial decision stages.
Identifiants
pubmed: 35047408
doi: 10.3389/fonc.2021.797454
pmc: PMC8761664
doi:
Types de publication
Journal Article
Langues
eng
Pagination
797454Informations de copyright
Copyright © 2022 Macchia, Ferrandina, Patarnello, Autorino, Masciocchi, Pisapia, Calvani, Iacomini, Cesario, Boldrini, Gui, Rufini, Gambacorta, Scambia and Valentini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Gynecol Oncol. 2012 Jun;125(3):594-9
pubmed: 22425663
J Am Coll Radiol. 2019 Sep;16(9 Pt B):1351-1356
pubmed: 31492414
Ann Oncol. 2018 Feb 1;29(2):418-423
pubmed: 29324970
Database (Oxford). 2020 Jan 1;2020:
pubmed: 32185396
Transl Lung Cancer Res. 2020 Jun;9(3):507-514
pubmed: 32676314
Br J Radiol. 2015;88(1055):20150385
pubmed: 26388108
J Natl Cancer Inst. 2019 Sep 1;111(9):923-932
pubmed: 30629194
Gynecol Oncol. 2010 Aug 1;118(2):128-33
pubmed: 20494419
Front Med (Lausanne). 2020 Feb 05;7:27
pubmed: 32118012
J Clin Oncol. 2010 Sep 20;28(27):4268-74
pubmed: 20585094
Eur J Surg Oncol. 2018 Jul;44(7):1062-1068
pubmed: 29753611
Int J Gynecol Cancer. 2017 Jun;27(5):1001-1008
pubmed: 28486242
Gynecol Oncol. 2010 Dec;119(3):404-10
pubmed: 20817228
Radiology. 2016 May;279(2):329-43
pubmed: 27089187
Biomed Res Int. 2021 May 4;2021:5584004
pubmed: 33997017
Comput Biol Med. 2020 Mar;118:103634
pubmed: 32174312
Oncologist. 2019 Jun;24(6):812-819
pubmed: 30181315
Am J Clin Oncol. 2010 Dec;33(6):577-82
pubmed: 20023568
Sci Rep. 2021 Oct 27;11(1):21136
pubmed: 34707184